1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsNo active RFA at this time; announcements will be posted when the next cycle opens.
Pilot Grant Program for Translational Stroke Studies is sponsored by University of Iowa Carver College of Medicine. A pilot grant initiative to encourage innovation in cerebrovascular translational science across campus, aiming to generate preliminary data for novel and promising stroke (ischemic & hemorrhagic) interventions.
Get alerted about grants like this
Save a search for “University of Iowa Carver College of Medicine” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Pilot Grant Program for Translational Stroke Studies | Institute for Clinical and Translational Science - The University of Iowa Pilot Grant Program for Translational Stroke Studies Pilot Grant Program for Translational Stroke Studies The University of Iowa Carver College of Medicine is sponsoring a pilot grant initiative to encourage innovation in cerebrovascular translational science across campus.
The University of Iowa is one of the 27 institutions selected as a regional coordinating center for NIH StrokeNet, a research network that aims to advance acute stroke treatment, prevention, and recovery by promoting translational research in stroke, as well as achieving efficiency in conducting clinical trials.
As part of this new network, the NINDS has initiated dedicated RFAs for translational research initiatives in stroke that can be tested through NIH StrokeNet in phase I-III trials. This pilot interdisciplinary award aims to help UI investigators across campus generate enough preliminary data for novel and promising stroke (ischemic & hemorrhagic) interventions.
Examples include treatment of acute stroke, recovery, prevention, as well as biomarkers (including neuroimaging). To be competitive for this unique funding opportunity related to NIH StrokeNet the project has to support or validate a promising therapy that can be eventually implemented in a StrokeNet clinical trial. Both basic and clinical science experiments will be considered.
Animal experiments should be translatable in nature, and therefore aiming to satisfy the NINDS requirements for development stroke therapies (STAIR & RIGOR criteria).
Human experiments should aim to generate preliminary data supportive of an eventual trial and includes, but are not limited to, Phase I dose-excalation studies, validating biomarkers (serum or imaging) or epidemiological analysis Faculty and trainees at the University of Iowa investigating novel stroke interventions (acute treatment, recovery or prevention), or biomarkers that could be used in intervention trials.
While post-doctoral students, fellows and clinical residents may apply, such applicants are required to have faculty members as co-investigators. Investigators should have an ongoing or planned partnership with physicians and staff of the Division of Cerebrovascular Diseases in the Department of Neurology and the UIHC Comprehensive Stroke Center.
Applicants are encouraged to work with members of the stroke division for guidance and suggestions before the submission. Funded projects are expected to work closely with translation stroke program. A two page application (Arial 11-point font with at least 0.
5 inch margins) will be needed for the initial selection process. The first page should include the following items: Preliminary Data (if available) Future plans for translation into stroke interventions Expected Impact on Improving Outcomes in stroke treatment, recovery, or prevention Plans for collaboration with the Cerebrovascular Division in the Department of Neurology. The second page should have an itemized budget.
Requests of up to $50,000 will be allowed. This program expects to fund two applications every 2 years. Applicants must justify their intended use of funds and are encouraged to take advantage of ICTS core resources.
Please note that grants will typically be funded for a two year period for a total of $50,000. Investigators must submit a new application to be considered for additional funding. In rare circumstances, pilot funds will support the purchase of necessary small equipment with proper justification.
Faculty salary or meeting travel will not be supported It is expected that pilot recipients will: Participate in and present their work at research seminars of the Division of Cerebrovascular Diseases Support an eventual U01 application as part of NIH StrokeNet Recognize the Carver College of Medicine for the grant support.
The pilot grant review committee is chaired by Dr. Marlan Hansen and includes members of the ICTS, Neurology, Epidemiology and Internal Medicine Departments. Proposals are reviewed according to five equally-weighted criteria for: Potential for improving stroke outcomes Potential for future funding through NIH StrokeNet. There is not an open RFA at this time.
It will be announced widely with details here when available.
According to the current listing, eligibility includes: Faculty and trainees at University of Iowa studying novel stroke interventions or biomarkers; postdocs/fellows/residents must have faculty co-investigators and partner with the Division of Cerebrovascular Diseases. Confirm the full requirements in the official notice before applying.
The current listing shows up to $50,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Pilot Grant Program for Translational Stroke Studies is funded by University of Iowa Carver College of Medicine. Verify program details on the funder's official page before applying.
This opportunity targets applicants in Iowa. If your organization operates elsewhere, check the official notice for location requirements.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
NIH's June 1 omnibus reset added Direct-to-Phase II to the STTR program for the first time. The change compresses university spinouts' funding timeline from three years to fifteen months, but the 30% research-institution subaward, feasibility-evidence rules, and IP licensing mechanics are not yet sorted at most universities.
Read articleDARPA and NSF launched a joint program on June 1 to fund university work on AI interpretability, control, and adversarial robustness. Awards run $750K to $3M+ per project, the forum launches this summer, and the universities listed in the AI Forge repository will sit closest to the money. The Request for Information closes June 22.
Read articleOn June 1, 2026, DARPA and the National Science Foundation announced AI Forge — a jointly governed forum that will fund, guide, and manage university-led research on AI interpretability, AI control, and adversarial robustness. The RFI on sam.gov closes June 22. The forum itself will be administered by a new nonprofit launching in summer 2026. The structure is what matters: this is not a one-off solicitation, it is a multi-year venue for university-government-industry research that operates outside the normal merit-review timelines of either agency. What university research teams should be doing in the seventeen-day window between the announcement and the RFI deadline — and what the forum model means for federal AI funding through FY 2028.
Read article